Mayo Clinic Trial on CBT for Quality of Life in Stage III-IV Melanoma Patients
A clinical trial is assessing the impact of cognitive behavioral therapy on quality of life for stage III-IV melanoma patients post-treatment.
Asset / Drug
Drug and asset intelligence for Quality with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.